Coverage
-
August 01, 2013
Becton Dickinson & Co. has struck a $22 million settlement agreement with hospitals and pharmacies whose class actions accused the New Jersey-based medical technology company of stifling competition from other hypodermic product makers, the company said in a Tuesday filing with the U.S. Securities and Exchange Commission.
2 other articles on this case.
View all »